Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201108380 Principal Investigator: Westervelt, Peter
Title: A Phase I Study of the Safety and Feasibility of Azacitidine after Donor Lymphocyte Infusion for Patients with Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation
Phase: I Disease Site: Myeloid and Monocytic Leukemia
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to determine whether it is safe to give patients azacitidine after administering donor lymphocytes, and whether doing this will reduce patients’ chances of experiencing Graft vs. Host Disease (GvHD).
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)